EUVIMEDEUVIMED entdecken
Crossref

The Advances in Stem Cell Therapy for Ischemic Stroke

Skye Dodge, Vincent S Gallicchio

Journal of Regenerative Medicine and Biology Research · 2026

DOI: 10.46889/jrmbr.2026.7103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Regenerative Medicine and Biology Research, 2026. Verfasst von Skye Dodge und 1 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemic stroke is a leading cause of death and long-term disability worldwide, resulting from the interruption of cerebral blood flow and subsequent neuronal injury. Current treatment strategies, including recanalization strategies, endovascular techniques, and neuroprotective agents, are limited by narrow therapeutic windows and the inability to promote neural regeneration. Stem cell therapy has emerged as a promising approach to restoring neurological function by replacing damaged tissues, decreasing inflammation, inhibiting apoptosis and enhancing endogenous repair mechanisms. Neural stem cells (NSCs) facilitate recovery through differentiation into neurons, astrocytes and oligodendrocytes, as well as the secretion of neurotrophic factors and modulation of the post-stroke environment. Both preclinical and early clinical studies have demonstrated improvements in motor function, gray and white matter recovery and functional brain improvements. Mesenchymal Stem Cells (MSCs) primarily exert paracrine and immunomodulatory effects, preserving the blood-brain barrier, reducing neuroinflammation and supporting neurovascular remodeling with intra-arterial, intravenous and intranasal delivery, showing safety and functional benefits in preclinical and limited clinical trials. Despite these promising findings, challenges such as limited NSC expandability, variable MSC sources and the influence of post-stroke microenvironment hinder clinical translation. This review will evaluate NSC and MSC based therapeutic strategies, highlight current limitations and explore emerging approaches to these fields. Overall, stem cell-based therapies hold significant potential for ischemic stroke recovery, permitting further investigation in both preclinical and clinical settings.

Zitieren

APA

Dodge, S., & Gallicchio, V. S. (2026). The Advances in Stem Cell Therapy for Ischemic Stroke. Journal of Regenerative Medicine and Biology Research. https://doi.org/10.46889/jrmbr.2026.7103

Vancouver

Dodge S, Gallicchio VS. The Advances in Stem Cell Therapy for Ischemic Stroke. Journal of Regenerative Medicine and Biology Research. 2026. doi:10.46889/jrmbr.2026.7103

BibTeX
@article{Dodge2026,
  author = {Dodge, Skye and Gallicchio, Vincent S},
  title = {The Advances in Stem Cell Therapy for Ischemic Stroke},
  journal = {Journal of Regenerative Medicine and Biology Research},
  year = {2026},
  doi = {10.46889/jrmbr.2026.7103}
}
Kostenlos starten →